Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

Matt Price drove his 73-year-old father Stephen from their New Jersey home to a medical strip mall on the Jersey Shore, for his first injection of an experimental drug called ...

Latest research shows how cannabis-derived medication helps Alzheimer's patients manage agitation, offering fresh hope to families and caregivers.

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...

Children who inherit genetic mutations from parents with early-onset Alzheimer’s typically show signs of dementia at the same ...

Antimicrobials, vaccines, anti-inflammatories linked to reduced risk for Alzheimer disease and dementia; antipsychotics and diabetes drugs tied to higher risk.

A recent study published in eLife offers a new perspective on the development of Alzheimer’s disease, suggesting that the ...

Verywell Health's content is for informational and educational purposes only. Our website is not intended to be a substitute ...

The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.